Biohaven (BHVN) Competitors $13.77 -0.39 (-2.78%) Closing price 09/24/2025 03:59 PM EasternExtended Trading$13.76 -0.01 (-0.05%) As of 06:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BHVN vs. NUVL, CRSP, RNA, MRUS, TGTX, PTCT, KRYS, ACLX, ACAD, and PCVXShould you be buying Biohaven stock or one of its competitors? The main competitors of Biohaven include Nuvalent (NUVL), CRISPR Therapeutics (CRSP), Avidity Biosciences (RNA), Merus (MRUS), TG Therapeutics (TGTX), PTC Therapeutics (PTCT), Krystal Biotech (KRYS), Arcellx (ACLX), ACADIA Pharmaceuticals (ACAD), and Vaxcyte (PCVX). These companies are all part of the "pharmaceutical products" industry. Biohaven vs. Its Competitors Nuvalent CRISPR Therapeutics Avidity Biosciences Merus TG Therapeutics PTC Therapeutics Krystal Biotech Arcellx ACADIA Pharmaceuticals Vaxcyte Biohaven (NYSE:BHVN) and Nuvalent (NASDAQ:NUVL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk. Is BHVN or NUVL more profitable? Nuvalent's return on equity of -32.58% beat Biohaven's return on equity.Company Net Margins Return on Equity Return on Assets BiohavenN/A -270.65% -143.70% Nuvalent N/A -32.58%-30.14% Do analysts recommend BHVN or NUVL? Biohaven currently has a consensus target price of $48.85, indicating a potential upside of 254.81%. Nuvalent has a consensus target price of $119.50, indicating a potential upside of 50.24%. Given Biohaven's stronger consensus rating and higher probable upside, equities research analysts clearly believe Biohaven is more favorable than Nuvalent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biohaven 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 3 Strong Buy rating(s) 3.13Nuvalent 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Do institutionals and insiders have more ownership in BHVN or NUVL? 88.8% of Biohaven shares are owned by institutional investors. Comparatively, 97.3% of Nuvalent shares are owned by institutional investors. 16.0% of Biohaven shares are owned by insiders. Comparatively, 10.2% of Nuvalent shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, BHVN or NUVL? Biohaven has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Nuvalent has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Does the media prefer BHVN or NUVL? In the previous week, Nuvalent had 2 more articles in the media than Biohaven. MarketBeat recorded 7 mentions for Nuvalent and 5 mentions for Biohaven. Nuvalent's average media sentiment score of 0.72 beat Biohaven's score of 0.47 indicating that Nuvalent is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biohaven 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nuvalent 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation and earnings, BHVN or NUVL? Nuvalent is trading at a lower price-to-earnings ratio than Biohaven, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiohavenN/AN/A-$846.42M-$7.66-1.80NuvalentN/AN/A-$260.76M-$4.90-16.23 SummaryNuvalent beats Biohaven on 8 of the 14 factors compared between the two stocks. Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHVN vs. The Competition Export to ExcelMetricBiohavenMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.50B$3.14B$5.78B$21.68BDividend YieldN/A2.36%5.68%3.52%P/E Ratio-1.8020.7675.9929.43Price / SalesN/A402.55543.8684.47Price / CashN/A45.9137.5624.47Price / Book3.299.8312.954.56Net Income-$846.42M-$52.73M$3.29B$1.00B7 Day Performance-11.41%1.84%0.81%-0.51%1 Month Performance-7.97%7.48%4.95%2.89%1 Year Performance-72.03%19.92%68.72%14.77% Biohaven Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHVNBiohaven3.2045 of 5 stars$13.77-2.8%$48.85+254.8%-69.4%$1.50BN/A-1.80239NUVLNuvalent3.1295 of 5 stars$79.37-1.4%$120.91+52.3%-21.5%$5.72BN/A-16.2040CRSPCRISPR Therapeutics3.2216 of 5 stars$57.84+2.8%$71.60+23.8%+30.5%$5.26B$37.31M-10.65460Analyst ForecastRNAAvidity Biosciences2.0964 of 5 stars$40.22-10.1%$68.94+71.4%-1.8%$5.17B$10.73M-11.30190Analyst ForecastHigh Trading VolumeMRUSMerus3.0469 of 5 stars$68.09-2.1%$88.75+30.3%+43.2%$5.15B$56.23M-12.3837Positive NewsTGTXTG Therapeutics4.2792 of 5 stars$31.75-1.3%$46.25+45.7%+51.9%$5.04B$329M85.81290Positive NewsPTCTPTC Therapeutics3.9275 of 5 stars$58.98-3.5%$69.00+17.0%+62.9%$4.69B$1.76B8.461,410Positive NewsKRYSKrystal Biotech4.9417 of 5 stars$155.71+8.4%$209.00+34.2%-9.7%$4.51B$290.52M31.65210Positive NewsHigh Trading VolumeACLXArcellx2.3218 of 5 stars$75.20-1.3%$114.31+52.0%-6.7%$4.17B$107.94M-21.9980ACADACADIA Pharmaceuticals4.3631 of 5 stars$24.67+4.5%$29.65+20.2%+34.2%$4.16B$957.80M18.55510Trending NewsAnalyst ForecastOptions VolumeGap DownPCVXVaxcyte2.0004 of 5 stars$31.00-3.6%$106.25+242.7%-71.6%$4.02BN/A-7.54160 Related Companies and Tools Related Companies Nuvalent Alternatives CRISPR Therapeutics Alternatives Avidity Biosciences Alternatives Merus Alternatives TG Therapeutics Alternatives PTC Therapeutics Alternatives Krystal Biotech Alternatives Arcellx Alternatives ACADIA Pharmaceuticals Alternatives Vaxcyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHVN) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
